Stephen Balevic, MD

Duke Clinical Pharmacometrics Center, Duke Clinical Research Institute (DCRI), Duke University School of Medicine

Disclosure(s): Purdue Pharma: Grant/Research Support; UCB: Advisor/Consultant

Poster(s):

• 232 - Population Pharmacokinetics (PopPK) of Ceftazidime-Avibactam (CZA) in Combination with Aztreonam (ATM) in a Phase I, Open-Label Study in Healthy Adult Subjects (COMBINE)
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 233 - Safety of Ceftazidime-Avibactam (CZA) in Combination with Aztreonam (ATM) in a Phase I, Open-Label Study in Healthy Adult Subjects (COMBINE)
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET